Deciphera Pharmaceuticals Completes Target Enrollment in the INTRIGUE Phase 3 Clinical Study of QINLOCK® (Ripretinib) in Patients with Second-Line Gastrointestinal Stromal Tumor – Top-line Results Expected in Second Half of 2021 –– Study Designed to Evaluate the...
Kit Check Launches Streamlined Mobile Pharmacy to Boost EfficiencyLucas McCanna December 8, 2020Medication management easily accessible through stocked medication cart WASHINGTON (December 8, 2020) — Kit Check, the leader in automated and intelligent medication...
Kyruus and HealthSparq Come Together to Transform Care Navigation Through Novel Payer-Provider Collaboration Kyruus Acquisition of HealthSparq from Cambia Health Solutions Provides Unparalleled Digital Access Platform to Connect People to the Right Care for Their...
Kyruus Named Winner of the Powerhouse Healthcare Company Category at New England Venture Capital Association’s 2020 NEVY Awards NEVY Award 2020 BOSTON — December 8, 2020— Recently, in homes all over New England, the New England Venture Capital Association (NEVCA)...
HARPOON THERAPEUTICS REPORTS CLINICAL PROGRESS ACROSS ALL FOUR TRITAC® PIPELINE DEVELOPMENT PROGRAMS HPN424 has shown confirmed partial response in treatment of metastatic castration-resistant prostate cancer in highest fixed dose cohort (160 ng/kg) of continuing...
Recent Comments